Latest News

Welcome to the Alfred Research Alliance news hub. To catch up on the news from our Alliance members, please click on the links below:

First human trial for COVID-19 vaccine in Southern Hemisphere begins at Alfred Research Alliance

Two Alliance members, Nucleus Network and 360biolabs, are facilitating the first human trial of a COVID-19 vaccine developed by US biotech company Novavax. In the race to find treatments and solutions for the COVID-19 pandemic, there are currently more than 100 coronavirus vaccines in development around the world – but only 10 have made it… Read More

Around the Precinct: 21 May 2020

How lockdown has influenced drinking habits, celebrating NHMRC grants, and the impact of COVID-19 on the Melbourne drug market – this week at the Alfred Research Alliance. Alfred Health Lockdown leads to spike in drinking While Victorians were locked down under stage 3 restrictions, alcohol sales increased 34% compared to the same time last year…. Read More

$30m+ in NHMRC Investigator Grants for Alfred Research Alliance

$30m+ in NHMRC Investigator Grants for Alfred Research Alliance

Member organisations from the Alfred Research Alliance have received a total of more than $30 million in the latest round of National Health and Medical Research Council (NHMRC) Investigator Grants, announced yesterday. The Investigator Grant scheme is the largest of the NHMRC’s funding schemes, and aims to support the research program of outstanding investigators at… Read More

Monash University SPRINT-SARI study

Around the Precinct: 14 May 2020

The first national snapshot of COVID-19 patients in Australian ICUs, celebrating International Nurses Day and why sitting less is good for our mental health – this week at the Alfred Research Alliance. Alfred Health Lifesaving trial moves to Tasmania Before COVID-19 struck, Natalia Rodriguez had been travelling from Launceston to The Alfred Oncology Unit every… Read More